• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴瘤或白血病患者对水痘-带状疱疹病毒感染的细胞介导免疫。

Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia.

作者信息

Patel P A, Yoonessi S, O'Malley J, Freeman A, Gershon A, Ogra P L

出版信息

J Pediatr. 1979 Feb;94(2):223-30. doi: 10.1016/s0022-3476(79)80828-8.

DOI:10.1016/s0022-3476(79)80828-8
PMID:762611
Abstract

Normal subjects and patients with lymphoma or leukemia were tested for the levels of lymphocytes, E-rosette--forming T-cells, serum and vesicle fluid interferon, and specific in vitro proliferative response to varicella-zoster antigen after clinical varicella or herpes zoster illness. The effect of polyinosinic acid/polycytidilic acid on the immune response was also evaluated. The development of VZ specific cell-mediated response in normal subjects was characterized by intense proliferative activity eight to ten days after the onset of illness, with significant decline 70 to 80 days later. The responses in subjects with lymphoma or leukemia were much lower. Few subjects with chickenpox or zoster with lymphoma or leukemia died during the infection. Death was associated with significant depletion of E-rosette--forming T-cells, and grossly deficient specific cellular response to VZ antigen. Treatment with Poly IC frequently induced elevations in serum as well as vesicle fluid interferon levels, and increased the proliferative activity of lymphocytes against VZ antigen.

摘要

对正常受试者以及淋巴瘤或白血病患者进行检测,测定其淋巴细胞、E 花环形成 T 细胞、血清和囊泡液干扰素水平,以及在临床水痘或带状疱疹发病后对水痘 - 带状疱疹抗原的特异性体外增殖反应。还评估了聚肌苷酸/聚胞苷酸对免疫反应的影响。正常受试者中水痘 - 带状疱疹特异性细胞介导反应的发展特点是发病后八至十天出现强烈的增殖活性,70 至 80 天后显著下降。淋巴瘤或白血病患者的反应则低得多。很少有患水痘或带状疱疹的淋巴瘤或白血病患者在感染期间死亡。死亡与 E 花环形成 T 细胞的显著耗竭以及对水痘 - 带状疱疹抗原的特异性细胞反应严重不足有关。聚肌苷酸胞嘧啶核苷酸(Poly IC)治疗常常导致血清以及囊泡液干扰素水平升高,并增加淋巴细胞对水痘 - 带状疱疹抗原的增殖活性。

相似文献

1
Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia.淋巴瘤或白血病患者对水痘-带状疱疹病毒感染的细胞介导免疫。
J Pediatr. 1979 Feb;94(2):223-30. doi: 10.1016/s0022-3476(79)80828-8.
2
Varicella-zoster antibody titers in children with leukemia and lymphoma. Relationship of titer to varicella-zoster infection.白血病和淋巴瘤患儿的水痘-带状疱疹抗体滴度。滴度与水痘-带状疱疹感染的关系。
Am J Dis Child. 1984 Jan;138(1):56-9. doi: 10.1001/archpedi.1984.02140390044013.
3
Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.通过迁移抑制试验评估的针对水痘-带状疱疹病毒的细胞介导免疫。
Acta Virol. 1980 Dec;24(6):406-14.
4
Clinical reinfection with varicella-zoster virus.水痘-带状疱疹病毒的临床再感染
J Infect Dis. 1984 Feb;149(2):137-42. doi: 10.1093/infdis/149.2.137.
5
Effect of transfer factor and zoster immunoglobulin in patients with varicella-zoster infection and malignancy.转移因子和带状疱疹免疫球蛋白对水痘-带状疱疹感染合并恶性肿瘤患者的影响。
Scand J Infect Dis. 1978;10(1):21-7. doi: 10.3109/inf.1978.10.issue-1.05.
6
[Varicella-zoster virus infections in the immunosuppressed child. Treatment with Acyclovir and controls].[免疫抑制儿童的水痘-带状疱疹病毒感染。阿昔洛韦治疗及对照]
Arch Fr Pediatr. 1983 Feb;40(2):95-9.
7
Humoral and cellular immunity to varicella-zoster virus: an overview.水痘-带状疱疹病毒的体液免疫和细胞免疫:概述
J Infect Dis. 2008 Mar 1;197 Suppl 2:S58-60. doi: 10.1086/522123.
8
Varicella-zoster antibodies in adult patient with haemoblastoses.
Zentralbl Bakteriol Orig A. 1976 Apr;234(3):413-6.
9
Radioimmunoassay for antibodies in varicella-zoster virus serology.水痘-带状疱疹病毒血清学中抗体的放射免疫测定
J Hyg Epidemiol Microbiol Immunol. 1979;23(3):332-9.
10
Selective decline in cellular immune response to varicella-zoster in the elderly.老年人对水痘-带状疱疹的细胞免疫反应选择性下降。
Neurology. 1980 Jun;30(6):582-7. doi: 10.1212/wnl.30.6.582.

引用本文的文献

1
Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.斯里兰卡原发性水痘带状疱疹病毒感染中的病毒载量、临床疾病严重程度及细胞免疫反应
PLoS One. 2008;3(11):e3789. doi: 10.1371/journal.pone.0003789. Epub 2008 Nov 21.
2
Recognition and treatment of shingles.带状疱疹的识别与治疗。
Drugs. 1994 Oct;48(4):528-48. doi: 10.2165/00003495-199448040-00004.
3
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system.利用骨髓成纤维细胞制备用于HLA限制性细胞毒性检测系统的靶标。
J Clin Microbiol. 1984 Oct;20(4):696-700. doi: 10.1128/jcm.20.4.696-700.1984.
4
Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.人多形核白细胞对水痘-带状疱疹病毒感染的成纤维细胞的细胞毒性作用。
J Virol. 1984 Jul;51(1):110-6. doi: 10.1128/JVI.51.1.110-116.1984.
5
Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.淋巴瘤患者复发性疱疹病毒感染发病机制中的细胞免疫和体液免疫
J Clin Invest. 1980 Apr;65(4):869-78. doi: 10.1172/JCI109739.
6
Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.老年人对水痘-带状疱疹病毒抗原的淋巴细胞增殖反应降低。
Infect Immun. 1981 Apr;32(1):24-7. doi: 10.1128/iai.32.1.24-27.1981.
7
Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms.
J Clin Immunol. 1986 Nov;6(6):472-80. doi: 10.1007/BF00915253.
8
Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients.正常人和免疫抑制的小儿白血病患者的淋巴细胞对水痘带状疱疹病毒感染细胞的裂解作用。
Clin Exp Immunol. 1985 May;60(2):387-95.
9
Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes.人单核细胞对细胞相关水痘带状疱疹病毒抗原的处理与呈递
Clin Exp Immunol. 1987 Oct;70(1):127-35.
10
Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood.水痘-带状疱疹病毒特异性细胞毒性T淋巴细胞(Tc):人类外周血中HLA I类限制性Tc的检测及频率分析
J Virol. 1987 Nov;61(11):3463-9. doi: 10.1128/JVI.61.11.3463-3469.1987.